Enanta Pharmaceuticals, Inc. To Host Conference Call On November 21 At 4:30 P.M. ET To Discuss Financial Results For Its Fiscal Fourth Quarter And Year Ended September 30, 2016
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that it plans to report its financial results for its fiscal fourth quarter and year ended September 30, 2016 after the U.S. markets close on November 21, 2016. Enanta management will host a conference call at 4:30 p.m. ET to discuss these results and provide an update on Enanta’s research and development pipeline.